We discuss actual with investors about raising BioCopy as novel method for Biomolecular Xeroxing. As Xeroxing is not so much know in Europe, we defined it as “biomolecular copier” and that’s finally BioCopy. If you are interested in information, the expose about BioCopy, simply contact the group leader Günter Roth for details (mail: guenter.roth(at)zbsa.uni-freiburg.de or call +49-761-203-97167).
Find out more on our official web page:
Or follow us on: